Jun 22, 2021 / 02:00PM GMT
Dylan Gering - Raymond James Financial - Analyst
Great, I'll kick this off. Raymond James is pleased to have TG Therapeutics present at the 2021 Human Health and Innovation Conference. From the Company, we have Michael Weiss, Executive Chairman, President and Chief Executive Officer. And with that, I'll turn this over to you, Michael, for the presentation.
Michael Weiss - TG Therapeutics, Inc. - Executive Chairman, President & CEO
Okay. Thanks. I appreciate it. Thanks, everyone, for joining us. Let me just share my screen here, which hopefully shouldn't be too challenging. Okay, hopefully this is -- lets you slide in. Okay, all right. So again, thanks, Raymond James, for having us today. And I will be making some forward-looking statements. So, for those who are interested, I do encourage you to review our public disclosure documents available on the Internet.
So, okay, perfect. So, by the way, just a quick way of background, Company was founded in 2012 with the goal to develop novel treatment options for patients with B-cell diseases. Those
TG Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 22, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers